Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05629572 · ClinicalTrials.gov registry record
Abbott i-STAT High Sensitivity Troponin I Study
A clinical trial, sponsored by Abbott Point of Care.
- Completed
- Registry status
- 3,697
- Enrollment target
NCT05629572 is a clinical trial that has completed, run by Abbott Point of Care. The registered enrollment target is 3,697 participants.
The verdict
NCT05629572 has completed, sponsored by Abbott Point of Care.
- COMPLETED
- Registry status
- 3,697 participants
- Enrollment target
Study Summary
The goal of this observational multi-center study is to evaluate the clinical performance of the i-STAT hs-TnI test (i-STAT High Sensitivity Troponin I) using the investigational i-STAT hs-TnI cartridge for the proposed intended use as an aid in the diagnosis and treatment of myocardial infarction (MI). The cartridge measures cardiac troponin I (cTnI) in whole blood or plasma samples using the i-STAT 1 Analyzer or i-STAT Alinity Instrument. Subjects presenting to the emergency department (ED) with chest discomfort or equivalent ischemic symptoms suggestive of Acute Coronary Syndrome (ACS) who are enrolled in this study will be asked to provide blood samples for testing.
Interventions
- DIAGNOSTIC_TEST i-STAT hs-TnI Cartridge Testing on i-STAT 1 and i-STAT Alinity
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,697 participants |
| Start Date | 2022-11-02 |
| Est. Completion | 2024-03-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05629572
The ClinicalTrials.gov registry entry for NCT05629572 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 3,697 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Point of Care, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which i-STAT hs-TnI Cartridge Testing on i-STAT 1 and i-STAT Alinity is the first listed.
NCT05629572 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05629572 about?
NCT05629572 is a clinical study titled "Abbott i-STAT High Sensitivity Troponin I Study". The goal of this observational multi-center study is to evaluate the clinical performance of the i-STAT hs-TnI test (i-STAT High Sensitivity Troponin I) using the investigational i-STAT hs-TnI cartridge for the proposed intended use as an aid in the diagnosis and treatment of myocardial infarction (...
What is the current status of trial NCT05629572?
This trial is currently completed. The enrollment target is 3,697 participants. The study started on 2022-11-02. Estimated completion is 2024-03-11.
What interventions are being tested in trial NCT05629572?
The interventions under investigation include: i-STAT hs-TnI Cartridge Testing on i-STAT 1 and i-STAT Alinity (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05629572?
This trial is sponsored by Abbott Point of Care, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.